Chordia Therapeutics Inc.
Announcement Regarding the Reduction of Capital Reserve and Appropriation of Surplus
Filed with TSE ·
On 6ix: 6ix.com/news/announcement-regarding-the-reduction-of-capital-reserve-and-appropriation-of-surplus
6ix is reading this filing.
View original source (TDnet)Chordia Therapeutics Inc. on 6ix
Story so far
Earlier from Chordia Therapeutics
- Fiscal year ended August 2026 Financial Results Presentation
- Non-consolidated Financial Results for the Fiscal Year Ended August 31, 2026 [Japanese GAAP]
- Announcement Regarding AMED Grant Award for rogocekib (CTX-712)
- Announcement Regarding Completion of Patient Enrollment in the Initial Expansion Cohort of rogocekib
- Announcement of Orphan Drug Designation in Japan for rogocekib for Relapsed or Refractory AML
Follow Chordia Therapeutics into a list and get an email when it puts out news.
Follow Chordia Therapeutics